Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Novavax (NVAX) vs. Competitors

2 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
CH:NVAXNovavaxCHF 1.21B-18.53―HoldUnlock the CH:NVAX analyst price target with TipRanks PremiumCH:NVAXUnlock the CH:NVAX top-analyst price target with TipRanks Premium
VIRVir Biotechnology$9.96$2.08B-7.9782.08%Strong BuyUnlock the VIR analyst price target with TipRanks PremiumCH:NVAX vs VIRUnlock the VIR top-analyst price target with TipRanks Premium
ORICOric Pharmaceuticals$7.86$881.05M-5.82-35.52%Strong BuyUnlock the ORIC analyst price target with TipRanks PremiumCH:NVAX vs ORICUnlock the ORIC top-analyst price target with TipRanks Premium
ABCLAbCellera Biologics$11.49$3.80B-23.94217.40%Strong BuyUnlock the ABCL analyst price target with TipRanks PremiumCH:NVAX vs ABCLUnlock the ABCL top-analyst price target with TipRanks Premium
SANASana Biotechnology$2.02$602.27M-3.81-44.81%Strong BuyUnlock the SANA analyst price target with TipRanks PremiumCH:NVAX vs SANAUnlock the SANA top-analyst price target with TipRanks Premium

Performance Comparison

-100%0%100%200%300%400%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
CH:NVAXNovavax―――
VIRVir Biotechnology9.964.4781.42%
ORICOric Pharmaceuticals7.86-4.20-34.83%
ABCLAbCellera Biologics11.497.89219.17%
SANASana Biotechnology2.02-1.62-44.51%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts